DJIA 16,768.90 91.00 0.55%
NASDAQ 4,472.12 19.33 0.43%
S&P 500 1,958.99 8.17 0.42%
market minute promo

4.39 0.01 (0.23%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OREX $4.39 0.23%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.40
Previous Close $4.38
Daily Range $4.30 - $4.41
52-Week Range $3.11 - $7.82
Market Cap $537.9M
P/E Ratio -5.34
Dividend (Yield) $0.00 (0.0%)
Volume 1,137,498
Average Daily Volume 4,653,293
Current FY EPS -$0.43





Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website:

News & Commentary Rss Feed

Could Arena Pharmaceuticals Inc. Be Running Out of Money?

Biotech stocks running out of money is a common concern for investors of clinical-stage and early commercial stage stocks. Let's take a closer look at Arena Pharmaceuticals' current cash situation and determine whether or not current investors should be worried.

Orexigen (OREX) Shows Strength: Stock Gains 11.1% - Tale of the Tape

Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads

Arena Investors Need To Watch Contrave Launch Closely

Orexigen Launches Contrave - Watch For Traction

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

Are People Too Concerned About Orexigen's Contrave Label?

Belviq Sales Dip: What To Watch For Ahead

Orexigen Up on $100M Milestone Payment from Takeda - Analyst Blog

What To Watch For As Orexigen's Launch Approaches

See More OREX News...

OREX's Top Competitors

OREX $4.39 (0.23%)
Current stock: OREX
AMGN $146.64 (-0.41%)
Current stock: AMGN
GILD $111.11 (3.67%)
Current stock: GILD
BIIB $320.13 (1.29%)
Current stock: BIIB